Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionRNA polymerase II cis-regulatory region sequence-specific DNA binding

BPTF ZNF746 GMEB2 KDM6B RREB1

7.86e-041244135GO:0000978
GeneOntologyMolecularFunctioncis-regulatory region sequence-specific DNA binding

BPTF ZNF746 GMEB2 KDM6B RREB1

8.67e-041271135GO:0000987
GeneOntologyMolecularFunctionRNA polymerase II transcription regulatory region sequence-specific DNA binding

BPTF ZNF746 GMEB2 KDM6B RREB1

1.62e-031459135GO:0000977
DomainPHD

BPTF PHRF1

1.21e-0375132PF00628
DomainZnf_PHD-finger

BPTF PHRF1

1.34e-0379132IPR019787
DomainPHD

BPTF PHRF1

1.69e-0389132SM00249
DomainZnf_PHD

BPTF PHRF1

1.77e-0391132IPR001965
DomainZF_PHD_2

BPTF PHRF1

1.93e-0395132PS50016
DomainZF_PHD_1

BPTF PHRF1

1.97e-0396132PS01359
Domain-

NSMCE2 BPTF PHRF1

3.30e-034491333.30.40.10
DomainZnf_RING/FYVE/PHD

NSMCE2 BPTF PHRF1

3.51e-03459133IPR013083
DomainZnf_FYVE_PHD

BPTF PHRF1

4.53e-03147132IPR011011
DomainZINC_FINGER_C2H2_2

ZNF746 ZNF804B RREB1

1.49e-02775133PS50157
DomainZINC_FINGER_C2H2_1

ZNF746 ZNF804B RREB1

1.50e-02777133PS00028
DomainZnf_C2H2-like

ZNF746 ZNF804B RREB1

1.60e-02796133IPR015880
DomainZnf_C2H2

ZNF746 ZNF804B RREB1

1.65e-02805133IPR007087
DomainZnF_C2H2

ZNF746 ZNF804B RREB1

1.67e-02808133SM00355
Domainzf-C2H2_6

ZNF746 RREB1

1.94e-02314132PF13912
Pubmed

Development of an efficient screening system to identify novel bone metabolism-related genes using the exchangeable gene trap mutagenesis mouse models.

BPTF WBP1L

7.62e-053513228106071
Pubmed

Tagging genes with cassette-exchange sites.

NSMCE2 BPTF PHRF1

2.36e-0433513315741177
Pubmed

Interaction network of human early embryonic transcription factors.

BPTF ZNF746 RREB1

2.70e-0435113338297188
InteractionELK3 interactions

ZNF746 GMEB2 RREB1

5.64e-05120133int:ELK3
GeneFamilyPHD finger proteins

BPTF PHRF1

8.62e-04909288
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

GJB3 KDM6B

3.14e-045062GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

BPTF GJB3 GMEB2 RREB1

2.34e-061761346546_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

BPTF GJB3 GMEB2

1.11e-041701333791_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

BPTF GMEB2 RREB1

1.15e-041721331072_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

BPTF GJB3 RREB1

1.17e-041731335950_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

BPTF GMEB2 KDM6B

1.17e-041731332881_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

BPTF GJB3 GMEB2

1.17e-041731332084_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

BPTF GJB3 GMEB2

1.21e-041751336736_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA

BPTF GMEB2 RREB1

1.21e-041751331058_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

BPTF GJB3 GMEB2

1.21e-041751336316_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

BPTF GJB3 GMEB2

1.23e-041761331212_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

BPTF GMEB2 KDM6B

1.29e-041791334483_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

BPTF GJB3 GMEB2

1.31e-041801331793_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

BPTF GJB3 GMEB2

1.35e-041821331891_DN
Drug0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A

BPTF WBP1L RREB1

1.35e-041821333630_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

BPTF GJB3 GMEB2

1.35e-041821331951_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A

BPTF GMEB2 RREB1

1.40e-041841332321_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

BPTF GMEB2 RREB1

1.44e-041861336874_DN
Diseaseanemia (phenotype), response to ribavirin

ZNF804B PHRF1

6.44e-069132EFO_0004272, GO_1901559
DiseasePeripheral Nervous System Diseases

CACNA1B GJB3

2.53e-0454132C4721453
DiseaseIntellectual Disability

CACNA1B BPTF KDM6B

8.82e-04447133C3714756
DiseaseOral ulcer

NSMCE2 RREB1

9.90e-04107132HP_0000155
Diseasemonocyte count

NSMCE2 WBP1L ZNF746 RREB1

2.06e-031320134EFO_0005091
Diseaseeosinophil count

NSMCE2 BPTF GMEB2 KDM6B

3.19e-031488134EFO_0004842
Diseaseeosinophil percentage of leukocytes

NSMCE2 BPTF KDM6B

3.81e-03746133EFO_0007991
Diseaseresponse to paliperidone, schizophrenia symptom severity measurement

NSMCE2 CACNA1B

3.95e-03216132EFO_0007925, EFO_0007927
Diseaseeosinophil percentage of granulocytes

BPTF KDM6B

4.61e-03234132EFO_0007996
Diseasebasophil count, eosinophil count

BPTF KDM6B

4.88e-03241132EFO_0004842, EFO_0005090
Diseasehypothyroidism

ZNF804B PHRF1

6.71e-03284132EFO_0004705
DiseaseInguinal hernia

BPTF RREB1

6.85e-03287132HP_0000023
Diseaselymphocyte:monocyte ratio

WBP1L KDM6B

6.90e-03288132EFO_0600088
Diseaseplatelet crit

NSMCE2 KDM6B RREB1

7.51e-03952133EFO_0007985
DiseaseParkinson disease

CACNA1B WBP1L

8.50e-03321132MONDO_0005180
Diseasegrip strength measurement

BPTF WBP1L

1.00e-02350132EFO_0006941
Diseasefree androgen index

WBP1L RREB1

1.14e-02374132EFO_0007005
Diseasesmoking status measurement

BPTF WBP1L ZNF804B

1.29e-021160133EFO_0006527
DiseaseC-reactive protein measurement

NSMCE2 BPTF RREB1

1.43e-021206133EFO_0004458

Protein segments in the cluster

PeptideGeneStartEntry
EVKKRRHRLKRHNDC

DEPDC7

51

Q96QD5
QHREDHDKRRHLAHK

BPTF

866

Q12830
HHHHRCHRRRDRKQR

CACNA1B

2051

Q00975
RRRDHHMVQRHLCDH

ADAMTS14

876

Q8WXS8
QQCDEHRRRAKELKH

GMEB2

321

Q9UKD1
SCKRRQKEHQKEHRR

KDM6B

971

O15054
QKEHQKEHRRHRRAC

KDM6B

976

O15054
LRRAIENHNKKRHRH

NSMCE2

231

Q96MF7
RLCRHKHQRERSHER

PHRF1

1131

Q9P1Y6
RERRHRQKHGDQCAK

GJB3

101

O75712
CFHKREHHSVERHKR

ZNF804B

741

A4D1E1
VRHQRIHQKARHAKH

RREB1

1556

Q92766
IRKDHLRKHQRNHAA

ZNF746

576

Q6NUN9
CHHRRAKHRLQAQQR

WBP1L

61

Q9NX94